DXC Technology

DXC · NYSE · Technology · United States

Financials at a glance

Source: SEC XBRL

Annual

FY2023FY2024FY2025FY2026$14.4B$14.4B$13.7B$13.7B$12.9B$12.9B$12.6B$12.6B0.1% margin0.1% marginRevenueNet margin

Quarterly · last 8

Q4 '23Q2 '24Q3 '24Q4 '24Q2 '25Q3 '25Q4 '25Q2 '26$3.4B$3.4B$3.2B$3.2B$3.2B$3.2B$3.2B$3.2B$3.2B$3.2B$3.2B$3.2B$3.2B$3.2B$3.0B$3.0B4.1% margin4.1% marginRevenueNet margin

Revenue (FY2026)

$12.6B

Net margin

0.1%

ROE

0.6%

Revenue CAGR (3y)

-4.3%

EPS (FY2026)

0.10

Net profit (FY2026)

$18.0M

Ask MarketChacha about DXC

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

  • Jul 28, 2026

    DXC rose on news of a new strategic AI partnership with ElevenLabs, including participation in its $500M funding round, building on its ongoing AI turnaround efforts.

    source 1source 2· confidence: high
  • Jul 24, 2026

    No clear company-specific catalyst in today's coverage or recent filings explains the move; DXC rose alongside broader sentiment around its AI turnaround efforts.

    source 1source 2· confidence: low

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

PeriodRevenueNet profitEPSNet marginROE
FY2026$12.6B$18.0M0.100.1%0.6%
FY2025$12.9B$389.0M2.103.0%12.0%
FY2024$13.7B$91.0M0.460.7%3.2%
FY2023$14.4B$-568.0M-2.48-3.9%-16.2%

Quarterly

PeriodRevenueNet profitEPSNet margin
2026Q2$3.0B$122.0M0.734.1%
2025Q4$3.2B$107.0M0.613.4%
2025Q3$3.2B$36.0M0.201.1%
2025Q2$3.2B$16.0M0.090.5%
2024Q4$3.2B$57.0M0.311.8%
2024Q3$3.2B$42.0M0.231.3%
2024Q2$3.2B$26.0M0.140.8%
2023Q4$3.4B$156.0M0.814.6%
2023Q3$3.4B$99.0M0.492.9%
2023Q2$3.4B$36.0M0.171.0%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.